These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28289840)

  • 1. Angioscopic and optical coherence tomographic evaluation of neointimal coverage: 9 months after expandable polyterafluoroethylene covered stent implantation.
    Kongoji K; Ishibashi Y; Kotoku N; Kasahara M; Yamazaki H; Mitarai T; Kamijima R; Koyama K; Yoneyama K; Tanabe Y; Akashi YJ
    Heart Vessels; 2017 Jun; 32(6):777-779. PubMed ID: 28289840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.
    Mizoguchi T; Sawada T; Shinke T; Yamada S; Okamoto H; Kim SS; Takarada A; Yasaka Y
    Int J Cardiol; 2014 Feb; 171(2):224-30. PubMed ID: 24388538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.
    Higo T; Ueda Y; Oyabu J; Okada K; Nishio M; Hirata A; Kashiwase K; Ogasawara N; Hirotani S; Kodama K
    JACC Cardiovasc Imaging; 2009 May; 2(5):616-24. PubMed ID: 19442950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy.
    Masawa T; Abe S; Toyoda S; Sakuma M; Nasuno T; Kageyama M; Tokura M; Koizumi S; Taguchi I; Inoue T
    Heart Vessels; 2016 Aug; 31(8):1230-8. PubMed ID: 26271923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCT Analysis of Very Early Strut Coverage of the Synergy Stent in Non-ST Segment Elevation Acute Coronary Syndrome Patients.
    Laine M; Dabry T; Combaret N; Motreff P; Puymirat E; Paganelli F; Thuny F; Cautela J; Peyrol M; Mancini J; Lemesle G; Bonello L
    J Invasive Cardiol; 2019 Jan; 31(1):10-14. PubMed ID: 30418164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overwhelming Suppression of Neointimal Coverage on High-Resolution Coronary Angioscopy After Paclitaxel-Coated Balloon Angioplasty for In-Stent Restenosis of Cobalt-Chrome Everolimus-Eluting Stent.
    Nojima Y; Nanto S; Adachi H; Ihara M; Kurimoto T
    Circ J; 2018 Sep; 82(10):2684-2685. PubMed ID: 29760309
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of drug-coated balloon angioplasty on in-stent restenotic coronary lesions analyzed with optical coherence tomography and serial coronary artery angioscopy.
    Akutsu N; Ogaku A; Koyama Y; Fujito H; Ebuchi Y; Migita S; Morikawa T; Tamaki T; Mineki T; Kougo T; Kojima K; Iida K; Murata N; Nishida T; Oshima T; Sudo M; Kitano D; Haruta H; Fukamachi D; Takayama T; Hiro T; Hirayama A; Okumura Y
    Heart Vessels; 2019 Dec; 34(12):1925-1935. PubMed ID: 31203393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography analysis of the stenting of saphenous vein graft (SOS) Xience V Study: use of the everolimus-eluting stent in saphenous vein graft lesions.
    Papayannis AC; Michael TT; Yangirova D; Abdel-Karim AR; Kohlhaas J; Mahmood A; Addo T; Haagen D; Makke L; Roesle M; Rangan B; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2012 Aug; 24(8):390-4. PubMed ID: 22865309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.
    Karjalainen P; Paana T; Ylitalo A; Sia J; Nammas W
    Acta Radiol; 2017 Sep; 58(9):1077-1084. PubMed ID: 28273737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomographic and angioscopic assessments of arterial healing in coronary artery perforation after implantation of zotarolimus-eluting stent.
    Ichikawa M; Kijima Y
    Int Heart J; 2013; 54(5):332-3. PubMed ID: 24097225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
    Sera F; Awata M; Uematsu M; Kotani J; Nanto S; Nagata S
    JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
    Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
    Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.